Dräger Infinity Kappa User Manual

17-2 DELTA/DELTA XL/KAPPA VF8
17 P
ULSE OXIMETRY (SPO2)
Overview
Dräger offers three algorithms for SpO
2
monitoring:
 Masimo SET
®

Nellcor Oximax
®

If installing VF8 software on monitors that do not have a Masimo SET logo
(see page 17-4) or a Nellcor OxiMax logo (see page 17-5), Dräger
OxiSure
(with connection via the MultiMed cables) is available.
These technologies enhance the quality of SpO
2
monitoring, allowing you to measure
the percentage of functional hemoglobin saturated with oxygen (% SpO
2
) in the
patient’s arterial blood. An SpO
2
sensor measures the absorption levels of red and
infrared light. The monitor uses the difference between the two measurements to
calculate the percentage of saturated hemoglobin. Because light absorption varies with
blood volume and blood volume varies with pulse rate, the monitor can also derive a
pulse rate (PLS).
The SpO
2
sensor, available for adult, pediatric, and neonatal patients is connected to
the monitor via the various MultiMed and NeoMed cables, or the Infinity
®
Masimo
SET SpO
2
SmartPod
®
, or the Infinity
®
Nellcor Oximax
®
SpO
2
SmartPod
®
pod.
Precautions
Refer to the “Safety Considerations” section starting on page 6, at the beginning of
these Instructions for Use, for general precautions regarding safe device operation.
SpO
2
measurements are particularly sensitive to the pulsations in the artery and the
arteriole. Measurements may not be accurate if the patient is experiencing shock,
hypothermia, anemia or has received certain medications that reduce the blood flow in
the arteries.
NOTE: For a complete list of Dräger provided SpO
2
accessories available with this
product, see page C-13.

Dräger Infinity Kappa Specifications

General

Brand	Dräger
Model	Infinity Kappa
Category	Medical Equipment
Language	English